Overview Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus Status: Recruiting Trial end date: 2022-12-01 Target enrollment: Participant gender: Summary Evaluation Dose Adjustments in Kidney Transplant Patients on Immediate Release and Extended Release Tacrolimus Phase: Phase 4 Details Lead Sponsor: Sentara Norfolk General HospitalCollaborator: Veloxis PharmaceuticalsTreatments: Tacrolimus